Riskpilot← Back to searchSign inGet full accessBIONORDIKA DENMARK A/S
A/SActiveCVR 17150774Marielundvej 46E, 2.Wholesale of other machinery and equipment · NACE 4664Est. 199311 employeeswww.bionordika.dk
Revenue 2025
DKK 14,6M
-10% vs 2024
EBITDA margin
41.6%
-23% vs 2024
Equity ratio
75.8%
Financial strength
Net profit 2025
DKK 4,7M
-25% vs 2024
| Revenue | DKK 14,6M | -10% |
| EBITDA | DKK 6,1M | -23% |
| Net profit | DKK 4,7M | -25% |
| Total assets | DKK 31,4M | +1% |
| Equity | DKK 23,8M | -7% |
| Employees | 11 | — |
Legal name
BIONORDIKA DENMARK A/S
CVR number
17150774
Legal form
Aktieselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
1. juli 1993
Share capital
DKK 500.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af selskabets samlede bestyrelse.
Company purpose
Selskabets formål er at drive handels- og agenturvirksomhed med biologiske reagenser og forbrugsvarer til laboratorier.
Address
Marielundvej 46E, 2.
Phone
+4539562000
Email
info@bionordika.dk
Website
www.bionordika.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 92.470 | 54.814 | 13.882 | 16.232 | 14.623 |
| Staff expenses | -8.047 | -8.041 | -6.820 | -8.364 | -8.534 |
| EBITDA | 84.423 | 46.773 | 7.062 | 7.868 | 6.089 |
| Depreciation & amort. | -242 | -98 | -145 | -220 | -211 |
| EBIT | 84.181 | 46.675 | 6.916 | 7.648 | 5.878 |
| Net financials | -712 | -36 | 1.125 | 406 | 195 |
| Profit before tax | 83.469 | 46.639 | 8.041 | 8.054 | 6.073 |
| Tax | 18.428 | 10.268 | 1.785 | 1.775 | 1.337 |
| Net profit | 65.041 | 36.372 | 6.257 | 6.279 | 4.737 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 120.175 | 65.228 | 34.442 | 31.221 | 31.449 |
| Equity | 87.696 | 59.068 | 29.324 | 25.604 | 23.840 |
| Long-term debt | 6 | 1 | 192 | 153 | 0 |
| Short-term debt | 32.473 | 6.159 | 4.925 | 5.464 | 7.494 |
| Total debt | 32.473 | 6.159 | 4.925 | 5.464 | 7.494 |
EBITDA margin
41.6%
This company
15.8%
Market median
+163% vs market
20212025
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
32.4%
This company
8.1%
Market median
+300% vs market
20212025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (4) | ||
ET | Audit | 1993 – 1994 |
HP Management | Management | 2012 – 2026 |
NE Management | Management | 1993 – 2003 |
PE Management | Management | 1993 – 1994 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2024 | |
| Chairman | 2025 | |
| Former (11) | ||
| Board of Directors | 2007 – 2012 | |
| Chairman | 2012 – 2013 | |
| Chairman | 2014 – 2015 | |
| Chairman | 2015 – 2022 | |
| Chairman | 1999 – 2003 | |
| Board of Directors | 1999 – 2003 | |
| Chairman | 2003 – 2012 | |
| Board of Directors | 2012 – 2013 | |
| Chairman | 2022 – 2025 | |
| Board of Directors | 2004 – 2007 | |
| Board of Directors | 2012 – 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIONORDIKA DENMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| Heinrich Preben Biehl | Management | 0 companies |
| Nils Erik Frandsen | Management | 0 companies |
| Kirsten Skovmøller Lysemose | Chief Executive Officer | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Lars Harald Gerne | Board of Directors | 0 companies |
| Nils Olof Jantze | Chairman | 0 companies |
| Morten Willemoes Dyrner | Chairman | 0 companies |
| Peter Simonsbacka | Chairman | 0 companies |
| Haakon Rivertz Torgersen | Board of Directors | 0 companies |
| Eva Irene Aarestrup Frandsen | Chairman | 0 companies |
| Maria Aarestrup Frandsen | Board of Directors | 0 companies |
| Bernt Anker Clausen | Chairman | 0 companies |
| Michael Hartmann | Board of Directors | 0 companies |
| Carl Gören Ragnvald | Board of Directors | 0 companies |
| Rolf Mattias Bengtsson | Chairman | 0 companies |
| Jussi Sakari Kurittu | Chairman | 0 companies |
| Bernt Søgaard Farver | Board of Directors | 0 companies |
| Arthur Bernardino | Board of Directors | 0 companies |